Immune Rejuvenation Jab Heads to Human Trials

Techno-optimist narrative

This new jab could genuinely reverse immune aging and help the body fight off cancer, HIV and dementia. The treatment targets worn-out T-cells, restoring the immune system's ability to recognize threats the way it did in youth. Early animal results have been impressive enough to spark serious optimism, with lifespan gains that would roughly translate to decades in human terms. With the first human trial set to begin this year, this approach could open an entirely new chapter in how we think about aging and disease.